Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1039620140040020131
Korean Journal of Family Practice
2014 Volume.4 No. 2 p.131 ~ p.136
The Relationship between Tumor Markers and Obesity
Kim Go-Eun

Jung Sung-Kweon
Chung Chi-Young
Kim Ji-Eun
Abstract
Background: Tumor markers are used to help in the early detection of cancer, to measure effectiveness after treatment, and to check for recurrence of cancer. Tumor markers are infl uenced by many factors. In this study, we analyzed the relationship between the representative tumor markers (alpha-fetoprotein [AFP], carcinoembryonic antigen [CEA], cancer antigen 125, cancer antigen 19-9 [CA19-9], prostatic specifi c antigen [PSA]) and obesity status using body mass index (BMI).

Methods: We calculated BMI based on height and weight of a total of 320 males and females who visited the health promotion center. The candidates were divided into a normal weight group, an overweight group, and an obese group according to their BMI. We analyzed the correlation between BMI and tumor markers.

Results: In the male obesity group, the correlation coeffi cients between BMI and AFP, CEA, CA19-9 were -0.214, -0.094, -0.213 which were all statistically insignifi cant (P=0.097, P=0.469, P=0.1). However, the correlation coeffi cient between BMI and PSA was statistically significant (-0.288, P=0.024). In men, the correlation coefficient between BMI and PSA was ?0.159 and it was statistically signifi cant (P=0.044). BMI was not signifi cantly correlated with any tumor markers in women.

Conclusion: Among tumor markers, only PSA showed signifi cantly negative correlation with BMI. It may be considered a reference point for PSA normal range according to obesity.
KEYWORD
Tumor Marker, Body Mass Index, Obesity, alpha-Fetoproteins, Carcinoembryonic Antigen, CA-125 Antigen, Cancer Antigen 19-9, Prostatic Specifi c Antigen
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) ´ëÇÑÀÇÇÐȸ ȸ¿ø